• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 531776 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417035837 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417035837 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Salix Pharmaceuticals Have Risen Above Previous 52-Week High

Published on Thu, 07/11/2013 - 18:13
By Peter Chu

Shares of Salix Pharmaceuticals (NASDAQ:SLXP) traded at a new 52-week high today of $69.66. This new high was reached on below average trading volume as 357,000 shares traded hands, while the average 30-day volume is approximately 600,000 shares.

Salix Pharmaceuticals (NASDAQ:SLXP) is currently priced 13.9% above its average consensus analyst price target of $59.39. Salix Pharmaceuticals shares have support at the 50-day moving average (MA) of $61.69 and additional support at the 200-day MA of $49.25.

In the past 52 weeks, Salix Pharmaceuticals share prices have been bracketed by a low of $37.52 and a high of $69.66 and are now at $69.02, 84% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 0.8%.

Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company's COLAZAL product is an anti-inflammatory drug used for the treatment of mildly to moderately active ulcerative colitis.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of V...

Shares of Varian Medical Systems (NYSE:VAR) traded at a new 52-week high today of $89.6 ...

UnitedHealth: The Winning Streak Continu...

Shares of UnitedHealth (NYSE:UNH) traded today at $98.74, breaking its 52-week high. A ...

Texas Instruments: 52-Week High Recently...

Shares of Texas Instruments (NYSE:TXN) traded at a new 52-week high today of $53.74. T ...

Recent 52-Week High Exceeded in Shares o...

Taiwan Semiconductor Manufacturing (NYSE:TSM) traded at a new 52-week high today of $23 ...

Shares of Hanover Insurance Rise Above P...

Shares of Hanover Insurance (NYSE:THG) traded at a new 52-week high today of $71.67. T ...

Recent 52-Week High Exceeded in Shares o...

Taubman Centers (NYSE:TCO) traded today at a new 52-week high of $79.47. So far today ...

Shares of Taser International Have Risen...

Taser International (NASDAQ:TASR) traded at a new 52-week high today of $22.35. Approx ...

Shares of Sunstone Hotel Investors Have ...

Sunstone Hotel Investors (NYSE:SHO) traded at a new 52-week high today of $15.93. This ...